MoneyWorks4Me

Dr. Reddy’s Laboratories informs about press release

01 Aug 2026 Evaluate
Dr. Reddy’s Laboratories has informed that it enclosed a Press Release, ‘Dr. Reddy's Laboratories Receives U.S. FDA Approval for Rituximab Biosimilar’.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1224.50
Cipla 1337.00
Lupin 1925.00
Zydus Lifesciences 1127.85
View more..